MoneyAM

ValiRx Share Price (VAL)

0.41 +0.03 (+6.49%) delayed: 5:52PM BST
Bid price 0.37 Open price 0.39
Ask price 0.45 Prev close 0.41
High price 0.37 Spread 17.78%
Low price 0.35 Volume 1,771,931

Register now for FREE live ValiRx share prices, ValiRx stock quotes, charts, trades and FREE ValiRx company fundamentals, market news and much much more. Why not upgrade to a premium service and get ValiRx Level 2 Data, indepth research tools and investor commentary for ValiRx (VAL) and other London Stock Exchange equities.

ValiRx Share Price Chart

Advanced Charts >>
You need to upgrade your Flash Player
You need to upgrade your Flash Player

Register now for FREE ValiRx share price charts

ValiRx Share Price Information

Name ValiRx Epic VAL
Activites Provides therapeutic and diagnostic research and development Reuters VAL.L
ISIN GB00B23N9136 Google Finance LON:VAL
Share Price (p) 0.41 Prev. Share Price (p) 0.41
Shares in Issue (m) 1,260 Market Cap (£m) 5
PE Ratio (x) Div per share (p) 0.00
Div yield (%) 0.00 Div cover (x)
EPS (p) -0.10 PEG

Register now for FREE ValiRx company fundamentals

ValiRx Director Deals

Dec.Date Type Director Pos No. of Shares
14/07/2011 BUY Satu Vainikka CEO 1,235,555
14/07/2011 BUY George Morris ED 538,770
14/07/2011 BUY Gerald Desler FD 538,770
14/07/2011 BUY Kevin Alexander NED 538,770
14/07/2008 SELL Satu Vainikka CEO 16,667

More ValiRx Director Deals >>

ValiRx Company News

09:53 15/05/2012

Valirx granted new US patent

ValiRx has announced that a method for cancer screening, using specific gene biomarkers in the field of genetics and oncology, has received patent approval by the US patent office. The granting of this latest patent means that ValiRx now has biomarker patent protection in both the US and across...

07:03 15/05/2012

FLASH: Valirx granted new US patent

Story provided by StockMarketWire.com

07:00 15/05/2012

New US Patent Grant

/* */ RNS Number : 3218D ValiRx PLC 15 May 2012   15 May 2012 ValiRx Plc ("ValiRx" or the "Company")   New US Patent Grant for ValiRx's Cancer Screening Gene Biomarker     ValiRx Plc (AIM: VAL), a life science company...

More ValiRx Company News >>

Register now for FREE ValiRx company news

ValiRx Share Price Discussions

24 days ago

"I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. lol (VAL)

Dr Satu Vainikka, CEO commented: "I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. With Chlamydia being diagnosed as the fastest growing sexually transmitted disease at the moment, our self-testing pack, as an affordable, easy -to-use...

Register now for FREE ValiRx share price discussions